Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Therapeutic Ratio With Hypo Fractionated Stereotactic Radiotherapy for Brain Metastases

NCT05346367 is registered in ClinicalTrials.gov with Haaglanden Medical Centre as lead sponsor.

NCT NCT05346367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05346367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Therapeutic Ratio With Hypo Fractionated Stereotactic Radiotherapy for Brain Metastases
Lead sponsor
Haaglanden Medical Centre
Phase
Not applicable
Overall status
Recruiting
Start date
July 18, 2022
Completion date
March 31, 2027
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases